1997
DOI: 10.1016/s0026-0495(97)90115-3
|View full text |Cite
|
Sign up to set email alerts
|

Elevated serum lipoprotein(a) levels in young women with endometriosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
15
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(16 citation statements)
references
References 46 publications
1
15
0
Order By: Relevance
“…In a later study, Crook et al 30 demonstrated that compared with levels in control subjects, the serum level of Lp(a) was 5 times higher in patients with endometriosis, possibly because of an immune response inherent to this disorder. Our findings, along with those of Crooke et al, 18,30 are in agreement with the assumption that in endometriosis, where baseline Lp(a) levels are increased because of the dysregulation of Lp(a) metabolism, danazol lowers Lp(a) concentration by controlling the inflammatory response. This is not the case in HAE, where baseline Lp(a) levels are normal and danazol has no significant influence on Lp(a) levels.…”
Section: Discussionsupporting
confidence: 93%
“…In a later study, Crook et al 30 demonstrated that compared with levels in control subjects, the serum level of Lp(a) was 5 times higher in patients with endometriosis, possibly because of an immune response inherent to this disorder. Our findings, along with those of Crooke et al, 18,30 are in agreement with the assumption that in endometriosis, where baseline Lp(a) levels are increased because of the dysregulation of Lp(a) metabolism, danazol lowers Lp(a) concentration by controlling the inflammatory response. This is not the case in HAE, where baseline Lp(a) levels are normal and danazol has no significant influence on Lp(a) levels.…”
Section: Discussionsupporting
confidence: 93%
“…Some earlier studies on women with endometriosis show that serum HDL and LDL are similar to that of age- and adiposity-matched controls, but serum lipoprotein (a) and triglycerides are elevated [31]. The relationship between endometriosis and known CVD risk factors is complicated by the fact that women with endometriosis have a lower BMI compared to controls [32, 33] and levels of fibroblast growth factor-2 (FGF-2) are elevated in women with endometriosis [34], since FGF-2 is known to protect against myocardial dysfunction [35].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, Crook et al (31) also observed significantly higher levels of serum lipoprotein(a) in women with endometriosis. Hence, women with endometriosis on danazol treatment are at a higher risk of developing cardiovascular diseases in later stages of their life.…”
Section: Figurementioning
confidence: 92%